Get started
Author

MJ Naughton

Idiopathic Recurrent Non-suppurative Focal Myositis: a Report of Two Cases
1993 · M. NAUGHTON, J. D. JESSOP, et al. · Lara D. Veeken · 29
RAD001 (everolimus) in combination with weekly paclitaxel and trastuzumab in patients with HER-2-overexpressing metastatic breast cancer with prior resistance to trastuzumab: a multicenter phase I clinical trial.
2009 · R O'Regan, F Andre, et al. · Cancer Research · 14
A phase II trial of a mammalian target of rapamycin inhibitor, temsirolimus, in patients with metastatic breast cancer.
2009 · OM Hahn, CX Ma, et al. · Cancer Research · 6
Abstract P5-13-04: A phase II neoadjuvant trial of MK-2206, an AKT inhibitor, in combination with anastrozole for clinical stage 2 or 3 PIK3CA mutant estrogen receptor positive HER2 negative (ER+HER2-) breast cancer (BC)
2016 · CX Ma, VJ Suman, et al. · Cancer Research · 3
Abstract OT1-02-10: A phase 2 study of poziotinib in patients with HER2-positive metastatic breast cancer (MBC) who have received prior HER2 regimens for MBC
2017 · K Lathrop, J Lucas, et al. · Cancer Research · 1
Abstract P1-15-05: Is absolute lymphocyte count associated with platinum-sensitivity? A phase II single arm study evaluating the efficacy of neoadjuvant carboplatin and docetaxel in triple negative breast cancer
2019 · I Chen, F Guo, et al. · Cancer Research
Abstract P2-09-09: The effects of treatment-induced symptoms, depression and age on sexuality in premenopausal women with early breast cancer receiving adjuvant endocrine therapy
2017 · K Ribi, W Luo, et al. · Cancer Research
Abstract P5-08-09: Differential patient stratification by the breast cancer index HoxB13/IL17BR ratio vs recurrence score (RS) plus quantitative ER expression in hormone receptor positive, node negative breast cancer
2016 · MJ Naughton, BE Schroeder, et al. · Cancer Research
Works count: 9
Citation count: 53
H-index: 3
I10-index: 2
Year
Topic
Type